USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note F - Operating Leases (Tables)

Note F - Operating Leases (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Assets and Liabilities, Lessee [Table Text Block]

				*January 2,*				*December 28,*
Leases		*Classification*		*2021*				*2019*
Assets
ROU operating lease assets, net		Other assets		$	27,947			$	31,263
Total ROU assets				$	27,947			$	31,263

Liabilities
Current:
Operating lease liabilities		Other current liabilities		$	8,616			$	8,323
Non-current:
Operating lease liabilities		Other long-term liabilities			12,856				17,274
Total lease liabilities				$	21,472			$	25,597

Lease, Cost [Table Text Block]

		Year Ended

		*2020*				*2019*
Lease cost
Operating lease cost		$	9,411			$	8,988
Total lease cost		$	9,411			$	8,988

		Year Ended

		*2020*				*2019*
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases		$	10,410			$	8,656
ROU assets obtained in exchange for new operating lease liabilities		$	6,632			$	13,575
Weighted-average remaining lease term—operating leases		3.13 yrs.				3.85 yrs.
Weighted-average discount rate—operating leases			3.55	%			3.75	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Year ending
2021		$	9,214
2022			5,822
2023			4,294
2024			2,523
2025			597
Thereafter			175
			22,625
Less: imputed interest			(1,153	)
Present value		$	21,472